MDClone raises $63M for health data startup and more funding for digital health


Health Data Company MDClone announced a Series C funding round of $63 million. This news comes two and a half years after the Israeli company announced its $26 million Series B. Warburg Pincus and Viola Growth led the round, with participation from aMoon, LightSpeed ​​Venture Partners and OrbiMed.

The startup has created a self-service data analytics platform designed to help healthcare systems access and organize their data. The system is designed to help customers find data insights that facilitate medical research and patient outcomes.

Customers can instruct the platform to create patient cohorts, grouping patients by any event on a patient’s timeline. The platform also allows users to see productivity over time. It may also use synthetic data to share information from other organizations.

The company plans to expand its services to new regional markets and expand its platform. It also seeks to include new markets in the life sciences and real-world evidence space.

“We had been looking to invest in the digital health space for some time and were fascinated by MDClone and the immense opportunity it brings to the healthcare system by democratizing healthcare data without risking exposing individuals’ data. The company has shown great progress over the past year and an even broader vision that we believe can transform the way physicians around the world can treat patients and improve care,” said Eran Westman, general partner at Viola Growth.

Health Benefits Navigation Tool Naiya announced a $55 million Series C funding round led by ICONIQ Growth. This news comes less than a year after the New York-based company shut down a $37 million Series B round.

The platform aims to help employees choose their insurance plans and then make the best use of the plan. It uses AI and data science to help give users personalized recommendations for plan selection. It also helped users find the best ways to save money.

The company plans to use the cash injection for product innovation and new partnerships.

“Over the past two years, there has been a dramatic increase in anxiety, loneliness and depression among countless people, dramatically changing the lives of workers in all sectors,” said Sina Chehrazi, co-founder and CEO of Nayya, in a statement.

“That’s why it’s so critical for organizations to deliver quality, personalized benefits and coverage plans to enable a dynamic, creative and engaged workforce. This investment is a vote of confidence in our mission to make the healthcare and benefits experience clearer, faster, more enjoyable, far more beneficial and economical.”

Synaptic medicine, a French startup that helps doctors prescribe the best drugs, raised $28 million in a funding round led by Korelya Capital, with participation from XAnge, MACSF and BNP Paribas Development. This new investment brings the company’s total fundraising to $40 million.

The Company’s platform provides clinicians with up-to-date, independent drug information. It also makes it possible to coordinate care with other prescribers. The service comes with a personal assistant that allows users to scan their prescription and look up drug labeling. It also helps patients communicate with doctors.

The new investment will be used to scale the platform in the US and Europe.

Canadian full stack digital health company Curve Health announced a C$5.1M seed funding round led by iGan Partners and Build Ventures. Kale Investment Fund, Globalive Capital and NewFund Capital also participated in this financing round.

Patients can access Curv for care navigation services and care plan management. Curv works with employers and health insurance companies to help connect members with healthcare providers. The company works in the areas of physical, nutritional and mental health.

“At the heart of the Curv Platform are a suite of digital tools that act as the ‘connective tissue’ between service providers and clients. These tools enable new pathways of care that use automation to reduce resources to help produce optimal results,” said Shea Balish, CEO of Curv Health.

“At the same time, these effective care pathways are helping independent healthcare providers rapidly scale their practice and revenue.”

Curv plans to use the money for product development and to hire for new roles.


Comments are closed.